Brazilian oncology chain announced a joint venture with a subsidiary of the Saudi Al Faisaliah Group to implement an oncology facility in Riyadh. Potential revenue at year five of the joint venture is estimated at USD 550 million.
LATEST NEWS
- Brazil’s Ambipar opens offices in Dubai, Abu Dhabi
- Saudi Arabia opens yerba mate market to Brazil
- Brazil export: Interest rate equalization prepaid
- Algeria to expand agricultural financing in 2025
- Brazil re-enters UNESCO alliance
- Climate events could affect Mauritania’s economy
- Saudi art exhibition in Rio offers poetic journey
- Morocco’s women rug weavers save age-old craft
